Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab emtansine in combination with atezolizumab or atezolizumab-placebo in HER2-positive locally advanced or metastatic breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-02-12